Answers are grounded in this paper and cite their sources.
The Centers for Medicare and Medicaid Services (CMS) recently announced the Maximum Fair Price for the first 10 Medicare Part D drugs selected for price negotiation. By February 2025, CMS should announce the list of Part D drugs to be negotiated with implementation of the negotiated prices in 2027.
No takes yet. Share an insight, caveat, or question.
Cousin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: